Article info

Download PDFPDF
Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate

Authors

  1. Address correspondence and reprint requests to Munekage Yamaguchi, MD, PhD, Department of Obstetrics and Gynecology, Faculty of Life Science, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto City, Kumamoto 860-8556, Japan. E-mail: munekage{at}hotmail.co.jp.

Citation

Erdenebaatar C, Yamaguchi M, Saito F, et al
Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate

Publication history

  • Received October 27, 2017
  • Accepted December 12, 2017
  • First published March 1, 2018.
Online issue publication 
March 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.